Skip to main content

Table 1 The correlation between VDAC1 expression and clinicopathological characteristics in BRCA patients

From: Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression

Characteristics

BRCA cohort

VDAC1 expression

P

(n = 527)

Low (n = 263)

High (n = 264)

Age (median)

59 (48–67)

57 (47–65)

60 (50–68)

0.053

Gender

  Male

6 (1.1)

2

4

0.414

  Female

521 (98.9)

261

260

Pathologic stage

  i

94 (17.8)

62

32

0.001

  ii

296 (56.2)

144

152

  iii

111 (21.1)

50

61

  iv

26 (4.9)

7

19

Pathology T stage

  T1

134 (25.4)

81

53

0.027

  T2

313 (59.4)

148

165

  T3

60 (11.4)

27

33

  T4

20 (3.8)

7

13

Pathology N stage

  N0

266 (50.5)

143

123

0.198

  N1

171 (32.4)

83

88

  N2

61 (11.6)

26

35

  N3

29 (5.5)

11

18

Pathology M stage

  M0

512 (97.2)

260

252

0.019

  M1

15 (2.8)

3

12

Radiation therapy

  No

262 (49.7)

121

141

0.089

  Yes

265 (50.3)

142

123

Metastasis

  No

212 (40.2)

119

93

0.019

  Yes

315 (59.8)

144

171